secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2026-08-05T20:07:17+00:00
Accession:  0001628280-26-053328
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q2 net income $18M vs loss; raises FY2026 guidance
----------------------------------------------------------------

- Total revenue $1.49B (+7% YoY); net income $18M vs net loss $104M in Q2 2025.
- Medical margin $197M vs negative $53M; Adjusted EBITDA $70M vs negative $83M.
- Total members 549,000 (down 10% YoY) due to disciplined contracting and market exits.
- FY2026 guidance raised: revenue $5,775-$5,860M, medical margin $465-$505M, Adj. EBITDA $75-$95M.
- Q3 2026 guidance: revenue $1,445-$1,475M, medical margin $105-$115M, Adj. EBITDA ($5)-$5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/0001628280-26-053328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/agl-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-053328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer